INTRODUCTION {#sec1-1}
============

For many years, it was the physician\'s role to diagnose the disease and write the prescription; while the pharmacist\'s role was only limited to compound and dispense these prescriptions.\[[@ref1]\] This practice has changed when clinical pharmacy commenced. Clinical pharmacy is a health science through which the clinical pharmacists optimize the use of medications, promote wellness, and prevent disease.\[[@ref2]\] The concept of clinical pharmacy was announced as a "hot new trend" in the 1960s by pharmacy educators as a new type of pharmacy practice, which is patient oriented rather than drug oriented.\[[@ref3][@ref4]\]

Al Hamarneh *et al*. affirmed that clinical Pharmacists\' interventions helped to minimize the incidence of death through several activities such as evaluation of drug utilization, providing educational services for patients, monitoring drug interactions, management of drug protocols, participating in medical rounds, and completion of admission drug histories.\[[@ref5]\]

Clinical pharmacists are crucial to promote the rational use of medications.\[[@ref2]\] They enhance the quality of patient care as they are the primary sources of valid and updated information regarding the safe, cost-effective, and rational use of medications.\[[@ref1]\] Chisholm-Burns *et al*. mentioned that incorporating clinical pharmacists as healthcare team members is a viable solution to improve the quality of healthcare.\[[@ref6]\]

The impact of clinical pharmacists\' interventions was evidenced in several specialties. Khalili *et al*. identified that clinical pharmacists in Iran enhanced the knowledge of physicians regarding adverse drug reactions.\[[@ref7]\] Khan Mohammed *et al*. highlighted that clinical pharmacists\' interventions in patients with diabetic nephropathy were effective in preventing the deterioration of renal function through patient counseling.\[[@ref8]\] Dashti-Khavidaki *et al*. stated that knowledge and practice of nurses regarding medications delivery via enteral catheters were significantly improved via clinical pharmacists lead educational programs.\[[@ref9]\] Loewen *et al*. revealed that the greater the time clinical pharmacists spent on clinical services, the better was their impact on healthcare.\[[@ref10]\]

In many countries, the relationship between clinical pharmacists and physicians is not ideal.\[[@ref1]\] In Nigeria, clinical pharmacists are having difficulty in establishing their identities as other healthcare professionals view their role as dispensers only.\[[@ref11]\] This is not limited only to developing countries as Rosenthal *et al*. mentioned that the limited support from physicians is one of the obstacles to the practice of clinical pharmacists in Canada.\[[@ref12]\] It was revealed that the main challenges that clinical pharmacists face are billing for service, reimbursement, work overload, acceptance by other healthcare providers, lack of knowledge, lack of training, and documentation.\[[@ref13][@ref14]\]

For clinical pharmacists to practice in the best of their abilities, they should have had good clinical pharmacy education as well as hospital training. Berhane *et al*. stated that the majority of physicians in Ethiopia expect clinical pharmacists are knowledgeable drug experts.\[[@ref15]\]

The American College of Clinical Pharmacy highlighted the importance of quality assurance of the clinical services that the clinical pharmacists offer.\[[@ref16]\]

Clinical pharmacy commenced in Sudan in 2001 as a subject in the undergraduate pharmacy curriculum. Postgraduate clinical pharmacy education was started in 2004 as a "2-year" master program. Thereafter, postgraduate clinical pharmacy education expanded further as several universities started master in clinical pharmacy programs.\[[@ref17]\] Unfortunately, unavailability of facilities, absence of resources, and unavailability of qualified and well-trained clinical pharmacists all challenge the success of clinical pharmacy education in Sudan.\[[@ref17]\]

Currently, more than a hundred of clinical pharmacists are being graduated every year in Sudan. However, their impact on healthcare was never assessed. The principal aim of this study was to explore the self-perception of clinical pharmacists regarding their impact on healthcare in Khartoum State, Sudan, how they think doctors perceive their impact, exploring the obstacles that clinical pharmacists are facing, and identifying what clinical pharmacists recommend for a better clinical pharmacy practice in Sudan.

METHODS {#sec1-2}
=======

This is a qualitative, cross-sectional, exploratory study that was conducted in March 2016 in Khartoum State, Sudan. In-depth individual telephone interviews were conducted with a convenient sample of 26 clinical pharmacists \[[Table 1](#T1){ref-type="table"}\] from 14 governmental teaching hospitals in Khartoum State, Sudan.

###### 

Participants\' demographic data
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A convenient sampling technique was used. The study was designed to explore views rather than to assume representativeness.\[[@ref18]\] E-mail invitations for participation in the study were sent to the list of clinical pharmacists in Khartoum State that was obtained from the Ministry of Health. The list contained the names of 85 clinical pharmacists. However, E-mails were provided for 69 pharmacists only. Invitation E-mails to participate in the study were sent to the whole list; nevertheless, only twenty pharmacists accepted to participate. Interview arrangements were made with those who agreed to participate. The interviews were held at the place of work of each clinical pharmacist. The stopping criterion for data collection was to stop when no new themes emerge from the interviews. After interviewing the twenty pharmacists and for the purpose of data saturation, further new participants were contacted and they agreed to participate. The new participants were introduced by resending E-mail invitations to the whole list of clinical pharmacists excluding those who already accepted to participate. Eight pharmacists agreed to participate, and those who responded earlier were contacted first.

When three of the new participants were interviewed, some new themes did emerge. However, when another three participants were interviewed, no new themes emerged. At this point, data saturation was thought to be reached.\[[@ref18]\] Covering letters containing information about the aim of the study were given to participants, and informed consent was obtained from each one.

One investigator conducted all the interviews to ensure consistency in data collection, and all interviews were conducted in the English language. The average length of each interview was between 30 and 45 min. A simple checklist of topics (rough topic guide) was used to begin and guide the conversations \[Supplementary Table 1\]. Probing and subsequent questions were developed during the interviews depending on participants\' answers.

###### 

Interviews main questions

###### 

Click here for additional data file.

Notepapers and audiotape recording were used to collect the data, which was then transcribed. Transcripts were produced in English and subsets were shown to interviewees to assess for the accuracy of content before analysis to ensure data credibility.\[[@ref18]\] The interviews were coded using thematic analysis. Manual categorization was used and categorization continued till all themes were identified.\[[@ref18]\]

To guarantee reliability and to allow for different perspectives, the field data were listened to, viewed, and coded by the first author to ensure consistency in coding. The second author independently assessed all codes. The two categorizations were then compared and any discrepancy was discussed and the final categorization was agreed on. Thematic analysis was carried out.\[[@ref18]\]

Computerized research records were stored in a password-protected computer while the hard copies were stored under lock and key. Data were protected effectively against improper disclosure when received, transmitted, and stored. The Faculty of Pharmacy, University of Khartoum Ethics Committee approved this study in January 2016.

RESULTS {#sec1-3}
=======

The paper revealed different themes regarding how clinical pharmacists perceive their impact on healthcare in Khartoum State, Sudan. It highlighted how they think other healthcare professionals perceive their impact. The paper also explored the tools that clinical pharmacists are using to communicate with doctors and in what form do clinical pharmacists give their recommendations. It identified the obstacles and challenges that clinical pharmacists are facing. Besides, this study also examined the opinion of clinical pharmacists on the curriculum of the master in clinical pharmacy programs they studied. The paper also explored their recommendations for a better clinical pharmacy practice. Participants were coded using the letter "C" followed by a number. The demography of the participants is shown in [Table 1](#T1){ref-type="table"}, and the main themes are shown in [Table 2](#T2){ref-type="table"}.

###### 

The main themes of the results
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The majority of participants affirmed that they did have an impact on healthcare but not to the level they aspire to:

"We do have an impact, but not to the level we aspire to" -- C1.

"To some extent, yes. We did positively impact healthcare, but we are only three clinical pharmacists and it is difficult for us to cover all aspects of the clinical pharmacy practice" -- C25.

Participants identified different roles that they practice at their hospitals including patients\' medications review, correcting medications errors, participating in daily medical rounds, participating in developing treatment plans, observing drug-drug interactions and adverse drug reactions, conducting therapeutic drug monitoring, developing guidelines, and offering patients counseling. Results showed variations in clinical pharmacy practice among the different hospitals. This may reflect the absence of central direction from health authorities:

"We correct doses, especially for anticoagulants, and inotropes. We reduce the unnecessary antibiotics prescribing. We also conduct educational activities including lectures, and educational brochures" -- C11.

"We participate in almost all clinical activities. Doctors consult us frequently regarding drug-related problems, and we revise patients\' files" -- C20.

Participants also mentioned that they made an improvement in the performance of drugs and therapeutics committees, and the drug information centers:

"We made a significant improvement in the performance of the drugs and therapeutics committee and the drug information center" -- C7.

Clinical pharmacists varied in their opinion regarding healthcare professionals\' acceptance of their role. The majority of participants mentioned that while nurses and junior doctors have good acceptance of their roles, senior doctors do not. This might be due to egotism of some senior doctors:

"...Doctors noticed clearly the improvement in practice that we made. They acknowledged that there is an improvement in patients\' treatment outcomes, and they welcome our role" -- C8.

"While junior doctors and nurses show good acceptance of our role, senior doctors do not" -- C9.

On the other hand, some pharmacists mentioned that junior doctors usually follow the practice of the senior doctor of the ward. Physicians who practiced outside Sudan have already been exposed to clinical pharmacists and are familiar with the concept of clinical pharmacy:

"Junior doctors believe that treatment plans are solely the responsibility of the senior doctor of the ward. Generally, consultants appreciate the role of clinical pharmacists, especially those who worked outside Sudan" -- C23.

Only one pharmacist mentioned that there are no acceptance and cooperation from doctors at all:

"There is no acceptance from doctors" -- C22.

Most of the participants revealed that the main tool of interaction between clinical pharmacists and doctors was the verbal discussion during clinical meetings. Besides, they use some printed materials such as educational brochures and posters.

"We discuss the cases with doctors during the rounds and clinical meetings. We also conduct lectures and use printed materials such as educational brochures and posters" -- C17.

One clinical pharmacist mentioned that they use green font pens to write their recommendations in patients\' files.

"We use green font pens to document our recommendations in patients\' files" -- C9.

Clinical pharmacists described several obstacles that they have been facing. They mentioned repetitively the lack of a specific section in patients\' files for them. They also mentioned the lack of training and the lack of continuous educational programs. The limited number of clinical pharmacists in hospitals was found to be among the key obstacles. Moreover, there was a lack of important facilities such as offices, libraries with up-to-date references, and Internet access. Besides, there are no national standard treatment guidelines or hospital formularies to benchmark doctors\' practices against. Clinical pharmacists also mentioned the lack of support from health authorities in terms of coordination with hospitals\' management and providing clear job descriptions. Clinical pharmacists\' salaries were described to be insufficient:

"Clinical pharmacy staff is limited. There are many drug-related problems that we cannot address because of staff shortage" -- C1.

"Our salaries are low. Hospital pharmacists who work at revolving drugs fund pharmacies are being paid higher salaries than we are" -- C20.

"We receive no support from the Ministry of Health in terms of training and job description" -- C12.

"We lack important tools such as offices, internet access, library with an up-to-date references, and a reliable laboratory for therapeutic drug monitoring" -- C23.

Participants showed significant variation in their assessment of the syllabus of the clinical pharmacy master programs they had. The majority of them revealed that it has important gaps that need to be addressed. They highlighted that the syllabus needs revision and amendments. Besides, they identified the need for improving the way of teaching. They also identified that the training period in hospitals was short. Clinical pharmacists described the therapeutics module as being more pharmacological than clinical. Besides, they highlighted that the content of the communication skills subject they studied during the master program was insufficient:

"Yes, it was good. I\'m satisfied with the master program, but some topics in the therapeutics module need improvement. It was more of basic pharmacology rather than being a clinical module" -- C7.

"I\'m not satisfied with the knowledge I gained from the master, especially the clinical training in hospitals and the module of therapeutics. During our studies, there was no clinical pharmacy preceptor in hospitals, but I think this problem was solved" -- C8.

"When we started practicing, we discovered that we lack communication skills" -- C11.

Participants recommended continuous educational and training programs. They strongly recommended increasing the number of clinical pharmacists in hospitals. Revisiting the master in clinical pharmacy syllabus was found to be of crucial importance. Participants also highlighted the importance of clinical pharmacy subspecialties. Besides, clinical pharmacists described the importance of clear job description and implementation guidance from health authorities. Increment in salaries was described as an important tool to ensure better practice:

"Our number in hospitals should be increased" -- C16.

"We need a clear job description, an increment in our salaries, and continuous training" -- C1.

"Guidelines and hospital formularies should be developed" -- C6.

"We should be provided with updated references, and access to an up-to-date literature" -- C21.

DISCUSSION {#sec1-4}
==========

The paper identified different themes regarding clinical pharmacists\' perception of their impact on healthcare in Khartoum State, Sudan. Most participants mentioned that they have positively impacted healthcare. However, they consider this as not to the level they aspire to. Similar studies that were performed in other countries also emphasized that clinical pharmacists did improve the quality of healthcare. In his paper, Lipton *et al*. revealed that clinical pharmacists improved the appropriateness of geriatric drug prescribing in outpatient settings.\[[@ref19]\]

Proper *et al*. studied the impact of clinical pharmacists in the emergency department (ED) of an Australian public hospital. The study revealed that after the implementation of the clinical pharmacy services at the ED, the percentage of medication errors decreased by 11%. About 59% of ED pharmacists\' medication interventions were clinically significant.\[[@ref20]\]

Moreover, studies also showed that clinical pharmacists have potential in reducing the unnecessary healthcare expenditures arising from drug-related problems. Lucca *et al*. found that clinical pharmacists in intensive care settings made 117 recommendations, of which 94% was accepted. The total net annualized cost savings made was 135205.22 USD.\[[@ref21]\]

Clinical pharmacists showed different views regarding healthcare professionals\' acceptance of their role. The majority of them mentioned that nurses and junior doctors have good perceptions of their roles while senior doctors do not. In a previous study in Sudan, Abdalla *et al*. assessed the perception of physicians about clinical pharmacists\' role in 28 hospitals. Of the total participants, 92.3% believed that clinical pharmacists are important healthcare team members.\[[@ref14]\]

Similar studies that were conducted outside Sudan also revealed the high acceptance of junior doctors and nurses for the role of clinical pharmacists. In the United Arab Emirates, Ibrahim and Ibrahim revealed that two-thirds of the physicians believed that pharmacists could act as a reliable source of general drug information and play an important role in discovering drug-related problems. It was found that the junior physicians had more appreciation to clinical pharmacists.\[[@ref1]\]

In Egypt, Sabry and Farid found that 50.5% of physicians reported that clinical pharmacists are their first source of information about drugs. Moreover, about one-third of physicians believed that pharmacists could be a reliable source of clinical information, identify drug-related problems, or advise the physicians about medication\'s cost effectiveness.\[[@ref22]\]

Concerning the master in clinical pharmacy programs, most of the participants showed dissatisfaction with the syllabus and training. No previous studies in Sudan assessed this issue. Mohamed reported that parallel to the introduction of the clinical pharmacy master program at the University of Khartoum, the pharmacy of Soba Hospital, Khartoum University\'s Teaching Hospital, was restructured to introduce more clinical services. This was considered as a major breakthrough in hospital pharmacy service upgrading in Sudan.\[[@ref17]\]

Clinical pharmacists described different obstacles and challenges in our study. Studies in other countries showed some similarities to our study including work overload and acceptance of doctors. Hale *et al*. stated that the main challenges that clinical pharmacists face are billing for service, reimbursement, work overload, acceptance by other healthcare providers, and documentation.\[[@ref13]\] Abdalla *et al*. pointed out that barriers to the practice of clinical pharmacy are time constraints, lack of self-confidence, lack of knowledge, lack of training, staff shortage, and lack of facilities.\[[@ref14]\]

The issue of the lack of regulations and support from health authorities was even reported in developed countries. In the UK, for example, it was found that clinical pharmacy is not practiced in a uniform manner in hospitals. The absence of central direction by the profession and the Department of Health has enabled this diversity to flourish.\[[@ref23]\]

Although many studies explored physicians\' perception about the role and impact of clinical pharmacists, to the best of our knowledge, this paper was the first one that explored the self-perception of clinical pharmacists of their impact on healthcare and how they think other healthcare professionals perceive their role. Moreover, it was the first one that assessed the master of clinical pharmacy programs from clinical pharmacists\' perspectives. The study did not explore the impact of clinical pharmacists from the perspectives of other stakeholders such as the doctors and patients. This might be a potential area for future research.

The study revealed that clinical pharmacists made a positive impact in improving the quality of healthcare in Sudan; however, this was not to the level clinical pharmacists aspire to.

Moreover, there is a considerable variation in the impact of clinical pharmacists on healthcare from one hospital to the other hospitals. Clinical pharmacists are looking for better practices, which can be achieved by addressing the different obstacles that are facing them. Providing continuous educational and training programs, specific sections in patients\' files to document pharmacists\' recommendations, increasing doctors\' awareness about the role of clinical pharmacists, and addressing the gaps in the master of clinical pharmacy programs are of crucial importance.
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